Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denufosol in Uveitis Associated Macular Edema
NCT00114062Phase 2Terminated
- Sponsor
- Merck & Co.
- Start
- Sep 2005
- Primary completion
- Dec 2006
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial comparing Denufosol Tetrasodium with Placebo (2 arms). Primary endpoints: Safety and tolerability of denufosol and Utility of denufosol in treating uveitis associated macular edema. Started Sep 2005; status: terminated.
02
Drugs
denufosol tetrasodium
Beyond the preview
Go deeper on NCT00114062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00114062.